Antigen delivery to mucosa-associated lymphoid tissues using liposomes as a carrier

Bioscience Reports

Volumn 22, Issue 2, 2002, Pages 355-369

  Zhou, Fan ^a   Neutra, Marian R ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Adjuvant; Antigen; IgA; Liposome; Mucosal immunity; Vaccine

Indexed keywords

ADJUVANT; ANTIGEN; CHOLERA TOXIN; DRUG CARRIER; IMMUNOGLOBULIN A; IMMUNOMODULATING AGENT; LIPOSOME; PHOSPHOLIPID; PULLULAN; VACCINE;

BILE; CELL TYPE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG STABILITY; GLYCOCALYX; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MUCOSAL IMMUNITY; NONHUMAN; PANCREAS JUICE; SHORT SURVEY; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ADMINISTRATION, RECTAL; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; BIOLOGICAL TRANSPORT; DRUG STABILITY; FEMALE; GASTRIC MUCOSA; GLYCOCALYX; HAPLORHINI; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; LIPOSOMES; MALE; MEMBRANE LIPIDS; PHOSPHOLIPIDS; VACCINATION; VACCINES, SUBUNIT;

EID: 0036555075     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020103109483     Document Type: Short Survey

References (63)

1. Abraham, E. (1992) Intranasal immunization with bacterial polysaccharide-containing liposomes induces antigen-specific pulmonary secretory antibodies. Vaccine 10:461-468.
2. Aramaki, Y., Tomizawa, H., Hara, T., Yachi, K., Kikuchi, H., and Tsuchiya, S. (1993) Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administration. Pharm. Res. 10(8):1228-1231.
3. Brandtzaeg, P. et al. (1999) Regional specialization in the mucosal immune system: What happens in the microcompartments? Immunol. Today 20(3):141-151.
4. Carey, M. C., Small, D. M., and Bliss, C. M. (1983) Lipid digestion and absorption. Annu. Rev. Physiol. 45:651-677.
5. Chaicumpa, W. et al. (1998) Immunogeneicity of liposome-associated and refined antigen oral cholera vaccine in Thai volunteers. Vaccine 16:678-684.
6. Chen, H., Torchilin, V., and Langer, R. (1996) Lectin-bearing polymerized liposomes as potential oral vaccine carriers. Pharm. Res. 13(9):1379-1383.
7. Chen, H. and Langer, R. (1997) Magnetically-responsive polymerized liposomes as potential oral delivery vehicles. Pharm Res. 14(4):537-540.
8. Chen, H. and Langer, R. (1998) Oral particulate delivery: Status and future trends. Adv. Drug Deliv. Rev. 34(2-3):339-350.
9. Childers, N. K., Denys, F. R., McGhee, J. F., and Michalek, S. M. (1990) Ultrastructural study of liposome uptake by M cells of rat Peyer's patches: An oral vaccine system for delivery of purified antigen. Regional Immunol. 3:8-16.
10. Childers, N. K. et al. (2000) Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen. Infect. Immun. 68(10):5509-5516.
11. Clark, M. A., Jepson, M. A., Simmons, N. L., Booth, T. A., and Hirst, B. H. (1993) Differential expression of lectin-binding sites defines mouse intestinal M-cells. J. Histochem. Cytochem. 41(11):1679-1687.
12. Clark, M. A., Hirst, B. H., and Jepson, M. A. (2000) Lectin-mediated mucosal delivery of drugs and microparticles. Adv. Drug Deliv. Rev. 43(2-3):207-223. Review.
13. Clark, M. A., Jepson, M. A., and Hirst, B. H. (2001) Exploiting M cells for drug and vaccine delivery. Adv. Drug Deliv. Rev. 50(1-2):81-106.
14. Clarke, C. J. and Stokes, C. R. (1992) The intestinal and serum humoral immune response of mice to orally administered antigens in liposomes II: The response to liposome-entrapped bacterial proteins. Vet. Immunol. Immunopathol. 32:139-148.
15. Conacher, M., Alexander, J., and Brewer, J. M. (2001) Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes). Vaccine 19(20-22):2965-2974.
16. Czerkinsky, C., Russell, M. W., Lycke, N., Lindblad, M., and Holmgren, J. (1989) Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect. Immun. 57:1072-1077.
17. Davis, D. and Gregoriadis, G. (1987) Liposomes as adjuvants with immunopurified tetanus toxoid: Influence of liposomal characteristics. Immunobiology 61(2):229-234.
18. Eldridge, J. H., Gilley, R. M., Stass, J. K., Moldoveanu, Z., Meulbroek, J. A., and Tice, T. R. (1989) Biodegradable microspheres: Vaccine delivery system for oral immunization. Curr. Top. Microbiol. Immunol. 146:59-66.
19. Eldridge, J., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R. M., and Tice, T. R. (1990) Controlled vaccine release in the gut-associated lymphoid tissues I: Orally administered biodegradable microspheres target to the Peyer's patches. J. Controlled Release 11:205-209.
20. Ermak, T. H. and Giannasca, P. J. (1998) Microparticle targeting to M cells. Adv. Drug Deliv. Rev. 34(2-3):261-283.
21. Florence, A. T. and Hussain, N. (2001) Transcytosis of nanoparticle and dendrimer delivery systems: Evolving vistas. Adv. Drug Deliv. Rev. 1:S69-S89.
22. Forrest, B. D. (1992) The need for consideration of mucosal immunity in vaccine approaches to AIDS. Vaccine Res. 1:137-142.
23. Frey, A. et al. (1996) Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: Implications for microbial attachment and oral vaccine targeting. J. Exp. Med. 184(3):1045-1059.
24. Gebert, A. and Hach, G. (1993) Differential binding of lectins to M cells and enterocytes in the rabbit cecum. Gastroenterology 105(5):1350-1361.
25. Gebert, A. and Posselt, W. (1997) Glycoconjugate expression defines the origin and differentiation pathway of intestinal M-cells. J. Histochem. Cytochem. 45(10):1341-1350.
26. Giannasca, P. J., Giannasca, K. T., Falk, P., Gordon, J. I., and Neutra, M. R. (1994) Regional differences in glycoconjugates of intestinal M cells in mice: Potential targets for mucosal vaccines. Am. J. Physiol. 267(6 Pt 1):G1108-G1121.
27. Giannasca, P. J., Giannasca, K. T., Leichtner, A. M., and Neutra, M. R. (1999) Human intestinal M cells display the sialyl Lewis A antigen. Infect. Immun. 67(2):946-953.
28. Glantz, P. O., Friberg, S. E., Christersson, C. E. and Baier, R. E. (1994) Surface and colloid chemical aspects of saliva particle interactions. J. Oral Rehabil. 22(8):585-588.
29. Han, Y., Morrison, R. P., and Cutler, J. E. (1998) A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect. Immun. 66(12):5771-5776.
30. Han, M., Watarai, S., Kobayashi, K., and Yasuda, T. (1997) Application of liposomes for development of oral vaccines: Study of in vitro stability of liposomes and antibody response to antigen associated with liposomes after oral immunization. J. Vet. Med. Sci. 59(12):1109-1114.
31. Haneberg, B., Kendall, D., Amerongen, H. M., Apter, F. M., Kraehenbuhl, J.-P., and Neutra, M. R. (1994) Induction of specific IgA in the small intestine, colon-rectum and vagina measured with a new method for collection of secretions from local mucosal surfaces. Infect. Immunity 62:15-23.
32. Harokopakis, E., Childers, N. K., Michalek, S. M., Zhang, S. S., and Tomasi, M. (1995) Conjugation of cholera toxin or its B subunit to liposomes for targeted delivery of antigens. J. Immunol. Methods 185(1):31-42.
33. Harokopakis, E., Hajishengallis, G., and Michalek, S. M. (1998) Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system. Infect. Immun. 66(9):4299-4304.
34. Hathaway, L. J. and Kraehenbuhl, J. P. (2000) The role of M cells in mucosal immunity. Cell Mol. Life Sci. 57(2):323-332.
35. Jepson, M. A., Mason, C. M., Clark, M. A., Simmons, N. L., and Hirst, B. H. (1995) Variations in lectin binding properties of intestinal M cells. J. Drug Target. 3(1):75-77.
36. Kozlowski, P. A., Cu-Uvin, S., Neutra, M. R., and Flanigan, T. P. (1997) Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect. Immun. 65(4):1387-1394.
37. Kraehenbuhl, J. P. and Neutra, M. R. (2000) Epithelial M cells: Differentiation and function. Annu. Rev. Cell Dev. Biol. 16:301-332. Review.
38. Lehner, T. et al. (1992a) Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 258:1365-1369.
39. Lehner, T., Panagiotidi, C., Bergmeier, L. A., Ping, T., Brookes, R., and Adams, S. E. (1992b) A comparison of the immune response following oral, vaginal, or rectal route of immunization with SIV antigens in nonhuman primates. Vaccine Res. 1:319-330.
40. Lindner, J., Geczy, A. F., and Russell-Jones, G. J. (1994) Identification of the site of uptake of the E. coli heat-labile enterotoxin, LTB. Scand. J. Immunol. 40(5):564-572.
41. Lycke, N., Tsuji, T., and Holmgren, J. (1992) The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 22(9):2277-2281.
42. Mazanec, M. B., Nedrud, J. G., Kaetzel, C. S., and Lamm, M. E. (1993) A three-tiered view of the role of IgA in mucosal defense. Immunol. Today 14(9):430-435. Review.
43. McClean, S. et al. (1998) Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia. Eur. J. Pharm. Sci. 6(2):153-163.
44. McGhee, J. R. and Mestecky, J. (1990) In defense of mucosal surfaces: Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens. Infect. Dis. Clin. North Amer. 4:315-341.
45. Michalek, S. M., Childers, N. C., Katz, J., Dertzbaugh, M., and Russell, M. W. (1992) Use of liposomes for induction of mucosal immunity. Vaccine Res. 1:241-249.
46. Neutra, M. R. and Kraehenbuhl, J.-P. (1992) Transepithelial transport and mucosal defense I: The role of M cells. Trends Cell Biol. 2:134-138.
47. O'Hagan, D. T., Palin, K., Davis, S. S., Artursson, P., and Sjoholm, I. (1989) Microparticles as potentially orally active immunological adjuvants. Vaccine 7:421-427.
48. Pappo, J., Ermak, T. H., and Steger, H. J. (1991) Monoclonal antibody-directed targeting of fluorescent polystyrene microspheres to Peyer's patch M cells. Immunology 73:277-280.
49. Patton, J. S. and Carey, M. C. (1979) Watching fat digestion. Science 204(4389):145-148.
50. Phillips, N. C., Gagne, L., Ivanoff, N., and Riveau, G. (1996) Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens. Vaccine 14(9):898-904.
51. Pierce, N. F., Sacci, J. B., Jr., Alving, C. R., and Richardson, E. C. (1984) Enhancement by lipid A of mucosal immunity of liposome-associated cholera toxin. Rev. Infect. Dis. 6:563-566.
52. Repa, J. J. et al. (2000) Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289:1524-1529.
53. Rubas, W., Banerjea, A. C., Gallati, H., Speiser, P. P., Joklik, W. K. (1990) Incorporation of the reovirus M cell attachment protein into small unilamellar vesicles: Incorporation efficiency and binding capability to L929 cells in vitro. J. Microencapsul. 7(3):385-395.
54. Russell-Jones, G. J. (2000) Oral vaccine delivery. J. Control Release 65(1-2):49-54.
55. Ryan, E. J., Daly, L. M., and Mills, K. H. (2001) Immunomodulators and delivery systems for vaccination by mucosal routes. Trends Biotechnol. 19(8):293-304.
56. Stremmel, W., Lotz, G., Strohmeyer, G., and Berk, P. D. (1985) Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J. Clin. Invest. 75(3):1068-1076.
57. Tomizawa, H. et al. (1993) Uptake of phosphatidylserine liposomes by rat Peyer's patches following intraluminal administration. Pharm. Res. 10(4):549-552.
58. VanCott, J. L., Kobayashi, T., Yamamoto, M., Pillai, S., McGhee, J. R., and Kiyono, H. (1996) Induction of pneumococcal polysaccharide-specific mucosal immune responses by oral immunization. Vaccine 14(5):392-398.
59. Velez, C. N., Tonkonogy, S. L., Lichtman, S. N. and Cho, M. J. (1997) Sensitized liposomes as an antigen delivery system for the stimulation of mucosal immunity. J. Drug Target 5(1):15-24.
60. Vankatesan, N. and Vyas, S. P. (2000) Polysaccharide coated liposomes for oral immunization-development and characterization. Int. J. Pharm. 203(1-2):169-177.
61. Watarai, S., Tana, Inoue, K., Oguma, K., Naka, K., and Kodama, H. (2000) Inhibitory effect of intestinal anti-Gb3 IgA antibody on verotoxin-induced cytotoxicity. Lett. Appl. Microbiol. 31(6):449-453.
62. Wolf, J. L. et al. (1981) Intestinal M cells: A pathway for entry of reovirus into the host. Science 212(4493):471-472.
63. Zhou, F., Kraehenbuhl, J. P., and Neutra, M. R. (1995) Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes. Vaccine 13(7):637-644.